Artelo Biosciences Inc. (NASDAQ: ARTL) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ARTELO BIOSCIENCES INC.

Artelo Biosciences Inc. (NASDAQ: ARTL)
Listen to this Section


$1.39
-0.0360 ( -2.52% ) 165.7K

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

Market Data


Open $1.39
Previous Close $1.43
Volume 165.7K
Market Cap $5.09M
Day Range $1.37 - $1.44
52 Week Range $1.19 - $85.80
Shares Outstanding 3.49M
Change % -2.52%
Net Change ▼ -0.0360
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2015
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -118,783.00

Date Type Amount Purchased Purchaser
2025-05-05 Buy 0.00 FAVORITO TAMARA A
2025-05-05 Buy 0.00 MATSUI CONNIE
2025-05-05 Buy 0.00 Gorgas Gregory D.
2024-03-01 Sale -8000.00 Reyes Gregory
2024-03-01 Sale -1200.00 Blayney Douglas
2024-03-01 Sale -1767.00 MATSUI CONNIE
2024-03-01 Sale -1484.00 Kelly Steven
2024-03-01 Sale -2000.00 FAVORITO TAMARA A
2024-03-01 Sale -834.00 EMANUELE ROBERT MARTIN
2024-03-01 Sale -5000.00 Gorgas Gregory D.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Apr 07, 2026
s-1 Registration statements 19 Apr 07, 2026
schedule Other 2 Apr 03, 2026
8-k 8K-related 22 Mar 30, 2026
8-k 8K-related 17 Mar 26, 2026
s-1/a Registration statements 5 Mar 24, 2026
s-1 Registration statements 18 Mar 24, 2026
s-1/a Registration statements 3 Mar 23, 2026
s-1 Registration statements 22 Mar 20, 2026
8-k 8K-related 17 Mar 18, 2026

Latest News


× Before browsing our site, please accept our cookies policy